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The Role of Primary 
Care Doctors in 
Early Diagnosis 
and Treatment 
for Persons with 
Dementia
Hong Kong is ageing fast . By 2041, 30% of the 
population will age over 65 years.1 Associated with 
this is a r is ing number of persons with dementia. 
The estimated local prevalence of dementia in the 
community is about 10% for the age segment 75-79 
years; 19% for 80-84 years; and 32% for 85 years and 
above. There is a preponderance of the female gender 
over the male.2, 3 These figures converge upon those 
of other advanced socioeconomic communities.4 The 
prevalence is projected to increase from 100,000 in 
2009 to over 330,000 by 2039.5
However, only 11% of people with dementia in the 
community have received a diagnosis.3 Barriers to timely 
diagnosis include low recognition of early symptoms 
and the need to seek medical attention; different views, 
fear and denial among family members; complexity 
in diagnosis with a lack of uniformed diagnostic and 
treatment protocols for different categories of dementing 
illness; and limited access to diagnostic services with 
very long waiting time.6-9 Closing the diagnosis and 
treatment gap will be particularly challenging with the 
projected rapid increase in prevalence and limited 
special ist manpower; this puts great pressure on 
diagnostic services.10
A diagnostic consultation for suspected dementia 
is important for establishing a clinical diagnosis and 
excluding non-dementing illnesses. Timely diagnosis 
a l lows commencement of ef fect ive symptomatic 
treatment (drug11, 12 and non-drug13); correcting risks 
and optimizing comorbidities; initiating psychoeducation 
for patient and caregiver; and advance care planning 
before the patient becomes mentally incapacitated. 
From a health economic perspective, it is cost saving 
from benefits such as delayed institutionalization and 
enhanced quality of life.11
Core Clinical Features of Alzheimer’s 
Disease and Other Dementias
In older-onset dementia, Alzheimer’s disease (AD) 
constitutes about 60% and vascular dementia (VaD) 
about 20% of all dementias, according to a local study.3 
There can be mixed forms of dementia. Non-ADs mainly 
refer to frontotemporal dementia (FTD) with behavioral 
disturbances and speech impairment as the early 
presentations; cerebral Lewy body disease (CLBD) with 
complex visual hallucination and rapid eye movement 
(REM) s leep behav ioura l d isorder , cor t icobasa l 
degeneration (CBD) with apraxia, and progressive 
supranuclear palsy (PSP) with gaze palsy, unsteady gait, 
and early swallowing dysfunction.14 
While dementia predominantly affects the older age, 
younger-onset dementia is increasingly recognized.15 
It affects an individual between 30 and 64 years old. 
About 50% of cases are caused by AD and VaD; FTD 
and other dementias have to be considered according 
to symptomatology and clinical examination.16
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Pathology and Diagnostic Workup 
The neuropathologies of AD are excessive extracellular 
accumulation of the protein beta-amyloid (Aß) resulting 
in plaques, and excessive intraneuronal accumulation 
of the protein tau resulting in neurofibrillary tangles. 
I n FTD, CBD, and PSP, tauopa thy i s the ma in 
pathology. In CLBD, aggregation of synuclein is mainly 
responsible.17 With the r is ing ageing populat ion, 
reversible dementias become lesser in prevalence 
compared with degenerative dementias.18 However, 
depression or pseudodementia, vitamin B12 deficiency, 
subdural haematoma, chronic alcoholism, normal 
pressure hydrocephalus, focal space occupying 
lesions, medication side effects, electrolyte imbalance, 
endocrine disorders and acute delir ium should be 
watched out for in the clinical assessment.
The 1984 NINCDS-ADRDA cr i ter ia for a l l -cause 
dementia and AD have recently been updated.19 A 
diagnostic pathway outl ined in Figure 1 can be a 
practical guide.
Figure 1. Diagnostic pathway for cognitive impairment
The DSM-5 renamed dementia as major cognit ive 
disorder. The new categorization places emphasis on 
evaluating various cognitive domains in the syndromal 
diagnosis of a condition. These domains as elaborated 
in the manual with associated symptoms include 
complex attention, executive function, learning and 
memory, language, perceptual-motor, and social 
cognition.20
Clinical Examination
In the clinical examination, commonly used and locally 
validated tools are the Mini-Mental State Examination,21 
clock drawing test,22 Geriatric Depression Scale,23 and 
the Clinical Dementia Rating scale.24 The Cantonese 
Chinese Montreal Cognitive Assessment has recently 
been validated locally for the detection of AD and 
amnestic MCI.25 In addition to general examination, look 
for lateralizing signs during neurological testing, which 
is not expected in AD. Unilateral corticospinal signs may 
indicate previous cerebrovascular event or a space-
occupying lesion. The presence of extrapyramidal 
MCI=mild cognitive impairment; EPS=extrapyramidal symptoms; HT=hypertension; AF=atrial fibrillation; CCF=chronic cardiac failure; 
DM=diabetes mellitus; CAD=coronary artery disease; TIA=transient ischaemic attack; CJD=Creutzfeldt-Jakob disease; PPA=primary progressive 
aphasia; AChEI=acetylcholinesterase inhibitor; FAST=Functional Assessment Staging Test for Alzheimer’s Disease; MRS=magnetic resonance 
spectroscopy; SPECT=single-photon emission computerized tomography; PiB-PET=Pittsburgh compound B positron emission tomography 
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signs may indicate non-AD such as CBD or CLBD; 
prominent palmomental reflex may indicate FTD or VaD. 
All positive signs should be interpreted in the context 
of the clinical history and symptoms. Cardiovascular 
examination should focus on the presence of atrial 
fibril lation, cardiomegaly and murmurs and carotid 
bruits, which give clinical impression on the vascular 
burden on the patient. The patient is then requested to 
walk and the gait assessed. Unsteady gait and shuffling 
may reveal underlying frontal involvement and atypical 
parkinsonism. A family history of cognitive disorders can 
be present in FTD especially in the younger-onset group.
Locally validated assessment
tools. 21-25
• Mini-Mental State Examination (MMSE)
• Clock drawing test (CDT)
• Geriatric Depression Scale (GDS)
• Clinical Dementia Rating (CDR)
• Montreal Cognitive Assessment (MoCA)
Laboratory Investigation
A dementia laboratory screen include complete blood 
picture, renal and liver functions, calcium, thyroid-
stimulating hormone, vitamin B12, folate, venereal disease 
research laboratory test, and chest x-ray. In older-onset 
dementia, mainly AD, biomarkers are complimentary 
only and neuroimaging such as CT brain may not be 
necessary;26 plain CT brain done will show generalized 
atrophy. CT brain is required if lateral izing sign is 
detected. In younger-onset dementias, more advanced 
neuroimaging is indicated, such as MRI for focal cortical 
atrophy and quantifying the hippocampus volume and 
brainstem atrophy; and functional imaging such as 
SPECT or PET, which will reveal specific hypoperfusion 
patterns in different dementias especially non-ADs. PiB- 
PET for amyloid load is considered to give additional 
clinical confirmation for younger-onset Alzheimer’s.15
Laboratory Screening
• Complete blood picture (CBP)
• Renal and liver functions, calcium (L/RFT, Ca)
• Thyroid-stimulating hormone (TSH)
• Vitamin B12, folate
• Venereal disease research laboratory (VDRL) test
• Chest x-ray
• Neuroimaging (e.g. CT brain)
Clinical Diagnosis of Dementia: Case 
Illustrations
Older-onset Alzheimer’s
An 85-year-old lady presented with cognitive decline 
noted by family members for 2 years and further decline 
in the past 9 months. History revealed confusion in 
the morning, no hallucinations, normal mood, difficulty 
signing, and hypertension. She was receiving methyldopa 
and amlodipine. Cl in ical examinat ion showed no 
lateralizing signs, palmomental reflex present, MMSE 
score of 17/30 (with 2 years of education), and positive 
CDT (Figure 2). Low level of vitamin B12 (168 pmol/L) was 
noted on screening tests. She was given a diagnosis 
of early AD. Treatment with donepezil 5 mg nocte and 
vitamin B12 150 μg bd was started.
Figure 2. Positive CDT in Patients with AD
In early AD, copying is better than drawing (executive function).
Cerebral Lewy Body Disease
An 80-year-old man presented with memory impairment 
noted for 2 years. He was observed to forget switching 
off stoves, losing his way in the street, and urinating in 
inappropriate places. He reported visual hallucinations 
and seeing a child in the apartment (phantom boarder) 
and the experience was not frightening. He had REM 
sleep behaviour disorder for 3 years and had hit his wife 
(now passed away) in sleep. History revealed dementing 
and parkinsonism features within the past 1 to 2 years, 
hypertension, and benign prostatic hyperplasia. Clinical 
examination showed masked face, stooped posture, 
bradykinesia, and shuffling gait. He scored 21/30 on 
MMSE (with 2 years of education) with positive CDT (Figure 
3). He was given a diagnosis of CLBD. Treatment with 
AChEI and low-dose carbidopa-levodopa was prescribed.
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Figure 3. Positive CDT in Patients with CLBD 
Profound visuopatial impairment thus similarly poor 
performance in both drawing and copying.
In CLBD, drawing and copying are both significantly impaired, with 
visuospatial dysfunction more profound than that observed in AD.
Clinical Staging
The early stages of AD, especial ly in older-onset 
pat ients, affect executive funct ion, memory, and 
visuospatial perception. Language is affected later 
on. FAST27 is a useful guide to stage AD. It can be 
applied to facilitate diagnosis: if temporal manifestations 
inconsistent with AD were noted, other medical causes 
for the symptom (e.g., incontinence, delirium) or non-
AD should be considered. Staging is also useful for 
prognostication and advising the patient and family 
members in advance care planning by predicting the 
next area and level of dysfunction in activities of daily 
living.
Dementia Case Identification in 
Practice: A Personal Experience 
Dr. TONG Kai Sing
I have taken part in a CME course organized by the 
Hong Kong Medical Association (HKMA) and Hong 
Kong Alzheimer’s Disease Association (HKADA). After 
the course, I became more aware of AD in my elderly 
patients.
There was an occasion when one of my patient, a 
72-year-old retired mathematics professor, who did 
not show up, despite making the appointment himself 
in the morning. When a nurse called to remind him, he 
denied of having making any appointment, although he 
was heard coughing on the phone. In the past, I would 
have disregarded this as an everyday mistake. However, 
being aware of the possibility of AD, I contacted his wife, 
who confirmed that she has witnessed her husband 
making the appointment that morning. On my request, 
the retired professor came with his wife and his son 
3 days later for a check-up. His wife told me that the 
retired professor was having behavioural problems, 
such as losing his temper more easily than before. He 
has been giving his grandson mathematics tutorials for 
years; however, for the past few months he was having 
some difficulties in teaching. There was also an episode 
when he could not f ind his door keys and became 
frustrated, while actually he was holding the keys in his 
left hand. He used to play golf twice a week, but now he 
claimed that he is too tired. The retired professor was 
later diagnosed of AD.
Another 78-year-old woman came to my clinic with her 
granddaughter, who had fever and cough. At the end of 
the consultation, she asked me, “By the way, Dr. Tong, 
I found my memory getting worse these few months. 
I found that I have many antihypertensive drugs left 
when I went to GOPD for regular follow-ups; my blood 
pressure was not as stable as before. I suspected that 
I have forgotten to take the drugs frequently.” Five days 
later, I arranged her husband and her daughter to come 
with her for the problems of her memory. Her husband 
noted an episode when the patient has inadvertently 
taken his antihypertensive rather than her own, and 
forgetting to turn off the gas after cooking. She noticed 
difficulties in finding her way home from the market for 2 
months. She was given a diagnosis of AD.
The CME course is offered in different districts. I find it 
very practical and useful. It has not only enhanced our 
knowledge in managing the patients with AD, such like 
the high morbidity and lack of support for majority of 
these patients in Hong Kong, but it has also highlighted 
the importance of early diagnosis and management for 
stabilizing the patients’ condition at the early stage of 
the disease. I also became aware of multidisciplinary 
professional teams at HKADA who provide full support 
to doctors, trainings and events for patients and their 
family members, and educational for the public. As a 
doctor, I found their early assessment and detection 
programme most helpful.
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Conclusion
A clinical diagnosis is the necessary condit ion for 
patients and families to access appropriate treatment 
and services. Being denied of their right to a diagnosis, 
unfortunately, is often the situation faced by many 
concerned elders and/or their family, due to various 
reasons including insufficient diagnostic services. A 
recent local survey showed that training increases 
the confidence in diagnosing and managing dementia 
among nonspecial ists.28 With proper training and 
support, such as shared care with specialists, primary 
care doctors have an important role in diagnosing and 
managing dementia.29, 30 Continuing medical education 
on the clinical features and diagnostic criteria goes a 
long way in ensuring timely diagnosis for those needing 
treatment and support services.
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1) Among people aged 85 years or above, AD is more common than other 
dementias.
2) Hallucinations is the most common presentation in early AD.
3) In early AD, the neurological examination usually shows signs of previous 
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the clock.
5) A positive CDT supports the diagnosis of AD.
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7) Complex visual hallucinations and REM behavioural disorder suggests CLBD. 
8) Subtle signs of parkinsonism is usually present in CLBD.
9) Hallucinations in CLBD should be treated with atypical neuroleptics.
10) CLBD should be treated with AChEI.
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